Gan&Lee Pharmaceuticals. Posted 197.6 Million Yuan Net Loss in First Half of 2022

Gan&Lee Pharmaceuticals. (甘李药业股份有限公司) (603087.SH) reported a net loss of 197.6 million yuan in the first half of 2022, reversing a net profit of 372.8 million yuan for the same period in the previous year.

Meanwhile, the company posted 834.8 million yuan in revenue, down 43.4% year-on-year.

At the end of the reporting period, it had 10.4 billion yuan in total assets and 602.3 million yuan in total liabilities, with a liability-to-asset ratio of 5.8%.